Discover#StartDisrupting
#StartDisrupting
Claim Ownership

#StartDisrupting

Author: Virginia Tech Corporate Research Center

Subscribed: 0Played: 0
Share

Description

#StartDisrupting is about the innovators, scientists, creatives, and designers who are disrupting and initiating positive opportunity and impact in new markets. The Virginia Tech Corporate Research Center’s CEO, Brett Malone, Ph.D. talks with companies that call our enterprise home, industry guests, partners, and stakeholders on everything from entrepreneurship, biotech to software, and more. www.vtcrc.com
15 Episodes
Reverse
About: Bruce Zoecklein & Mickey Cowden Cowden Family Farms vineyard and Cowden TechnologiesCreating Virginia wines that showcase the uniqueness of being grown and produced in the Appalachian Region.Enology and Viticulture @ Virginia TechResearch in enology is focused primarily in the area of grape and wine flavor components in addition to evaluation of vineyard management and processing alternatives. The influence of grapevine canopy management on the incidence of fruit rot metabolites and their effect on native grape aroma components is currently being investigated. Viticultural and enological practice affecting grape phenols and their polymerization and stabilization is also investigated. The evaluation of new cultivars and the wines produced from those cultivars attempts to provide practical information to enhance the growth and development of the Virginia wine industry.Emphasis AreasRelationships between vineyard management and grape aroma componentsGrape and wine flavor component isolation and characterizationGrape and wine phenols and phenol stabilityProcessing methodologies for flavor enhancementEvaluation of new cultivarsThe Analytical Services Laboratory, part of the Wine/Enology Grape Chemistry Group at Virginia Tech, was established to fulfill the analysis requirements of the regional wine industry.  The goal of this analysis program is to provide very rapid turn-around, with optimum precision and accuracy.Designed as a fee-based, full-service enology laboratory, we provide chemical, physical, microbiological and sensory analyses, including standardized reagents.  The services are available to wineries in any state, including importers and wholesalers.  Additionally, we provide analytic procedures to the individual wineries as requested.  These procedures are equipment-relevant, and do not necessarily reflect the types of analyses performed at the Enology Service Lab.For data reporting a secure website has been established.  Results of analyses are only available to the individual winemaker and to select staff members of the Enology Service Lab.  The data is posted as results are obtained.  Results of previous analysis are continuously maintained, allowing winemakers to see trends in their juice, must, or wine samples.  The website is continuously monitored for security and system back-ups are performed daily to provide the utmost in stability, security, and availability.
Follow Pallabi Saboo on LinkedIn Harmonia Holdings Group, LLC was born in 2006 at Virginia Tech’s Corporate Research Center in Blacksburg, VA. We wanted to bring innovation and change to the federal IT sector. We believed (and still believe today) that with shrinking federal budgets, there are huge opportunities to bring more efficiency to government through emerging technologies. We are a fun-loving, hard-working team of close to 400 professionals who are relentless in our pursuit of high-quality, cutting-edge solutions for our customers.Thanks to RAMP,  for allowing us to record at their location in Roanoke, VA.Founded in 2017 with funding from GO Virginia, the City of Roanoke, and Virginia Western Community College, RAMP through 2020 has nurtured 24 startup businesses. In September 2020, RAMP received a major endorsement by the U.S. Economic Development Administration, which awarded a nearly $1 million grant to Valleys Innovation Council — a nonprofit organization dedicated to growing the region’s innovation economy — to double RAMP’s output.
Gary Warren currently serves as president and CEO of ivWatch and has championed the development of non-invasive biosensors that fulfill a huge patient safety need in healthcare. Starting ivWatch in 2010, Gary assembled a team of leading scientists, clinicians, hospitals, and investors to solve a common drug delivery problem of IV infiltration and extravasation. Gary has guided ivWatch through multiple FDA and ISO clearances for this breakthrough technology with ivWatch products now being sold on the international market. Gary has a multidisciplinary background with a 14-year career as a research scientist at NASA in aerospace and computational fluid dynamics. He then left NASA to start a successful Internet infrastructure company in the mid-1990’s and served as CEO until it’s sale to Symantec in 1999. At Symantec, Gary served as a senior vice president and oversaw advanced technologies, mergers and acquisitions and gateway software products. He also served as a member of the senior executive staff. After Symantec, Gary served as CEO for a venture-backed mobile platform company as smartphones were beginning to emerge as a market. After the sale of this company to Oracle, Gary worked for various venture capital companies doing financial analysis and due diligence which brought him to the work being done on IV infiltrations under a National Institutes of Health grant. Bringing over the core engineering talent and founding the company, Gary has grown ivWatch to an award-winning brand in healthcare that is changing the standard of care for IV therapy.About ivWatch, LLC  ivWatch, LLC is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative IV monitoring solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch, Facebook @ivWatchLLC, and LinkedIn @ivWatch-LLC, or visit www.ivWatch.com.  
Links of interest:Zero to One -  Notes on Startups, or How to Build the FutureTED talk -  The CEO of Carbon3D, Joseph DeSimone has made breakthrough contributions to the field of 3D printing. The perfect fit: Carbon + adidas collaborate to upend athletic footwear - full storyLinkedIn profile  →  Joe co-founded Carbon in 2013. Under his direction, Carbon is marrying the intricacies of molecular science with hardware and software technologies to advance the 3D printing industry beyond basic prototyping to 3D manufacturing. Throughout his career, Joe has published over 350 scientific articles and has nearly 200 issued patents in his name — with more than an additional 200 patents pending. Joe also previously co-founded several companies including Micell Technologies, Bioabsorbable Vascular Solutions, and Liquidia Technologies.As Board Chair, Joe is currently on leave from his roles as Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill and William R. Kenan, Jr. Distinguished Professor of Chemical Engineering at North Carolina State University and of Chemistry at the University of North Carolina. He received his BS in Chemistry from Ursinus College, and his Ph.D. in Chemistry from Virginia Tech.Joe is one of only roughly 20 individuals who have been elected to all three branches of the U.S. National Academies: the National Academy of Medicine (2014), the National Academy of Sciences (2012) and the National Academy of Engineering (2005). During his career he has received over 50 major awards and recognitions, including the 2018 National Academy of Sciences Award for Convergent Science; the 2017 $250,000 Heinz Award for Technology, the Economy and Employment; the National Medal of Technology and Innovation, awarded by President Barack Obama in 2016; the inaugural $250,000 Kabiller Prize in Nanoscience and Nanomedicine; 2015 Dickson Prize from Carnegie Mellon University; 2014 Kathryn C. Hach Award for Entrepreneurial Success from the ACS; the 2010 AAAS Mentor Award in recognition of his efforts to advance diversity in the chemistry PhD workforce; the 2007 Collaboration Success Award from the Council for Chemical Research; and the 2002 Engineering Excellence Award by DuPont.
Gary Noesner retired from the FBI in 2003 following a 30 year career as an investigator, instructor, and negotiator.   A significant focus of his career was directed toward investigating Middle East hijackings in which American citizens were victimized.   In addition, he was an FBI hostage negotiator for 23 years of his career, retiring as the Chief of the FBI’s Crisis Negotiation Unit, Critical Incident Response Group, the first person to hold that position. In that capacity he was heavily involved in numerous crisis incidents covering prison riots, right-wing militia standoffs, religious zealot sieges, terrorist embassy takeovers, airplane hijackings, and over 120 overseas kidnapping cases involving American citizens.Following his retirement from the FBI he became a Senior Vice President with Control Risks, an international risk consultancy, assisting clients in managing overseas kidnap incidents.   He continues to Consult independently and speaks at law enforcement conferences and corporate gatherings around the world.He has appeared in numerous television documentaries about hostage negotiation, terrorism, and kidnapping produced by the History Channel, Nat Geo, WE, Discovery, TLC, A&E, CNN, CBS, BBC, American Heroes Network, and others.  He has been interviewed in Time, Forbes, the New Yorker, the Washington Post, the New York Times, Roll Call, the Washingtonian Magazine, the Christian Science Monitor, and other publications.  He has given speeches at major universities, done interviews on numerous radio and television programs, and was the subject of an hour long interview on NPR’s Fresh Air in 2010.He has written a book about his FBI negotiation career which was published by Penguin Random House in 2010, entitled:   Stalling for Time:  My Life as an FBI Hostage Negotiator.    The book is being used in part as the basis for a six part mini-series on Waco that will air on the Paramount Network on January 24, 2018.Gary has three grown children and resides in Virginia with his wife, Carol.
Disruption and the bridge of familiarity… Jason Feifer (Editor-in-Chief of Entrepreneur Magazine, author, speaker, and host of Build for Tomorrow podcast) talks on change, advice and all things for entrepreneurs and startups.https://www.jasonfeifer.com/build-for-tomorrow/Build for Tomorrow, Not for YesterdayComing in Summer, 2022: Jason's guide to resilience, and how to adapt and use the power of change to your advantage, drawn from centuries of innovations and the greatest minds of today. https://www.jasonfeifer.com/build-for-tomorrow-book
With over ten years of experience in the field of sport and performance psychology,  Pete has worked with a wide variety of performers, including everyone from youth to D1 athletes, tactical populations, weight management clients, and athletes returning from injury.  His drive is to help people develop the capacity for sustained success, no matter what your goals are.Show links:Web: www.drkcoaching.comInstagram: @alldaydr.kPodcast: Mental Training Lab
Linda Drake, Microsoft Federal Account Executive for the National Security Group, talks about new opportunities for federal funding.Linda Drake works for Microsoft Federal as an Account Executive for the National Security Group. She is also a small business Partner at Technology Transfer Consultants (T2C), a software development company that builds innovative products, connecting research interests to technology gaps. www.t2cpartners.comLinda has been in sales, business development and account management for over 35 years.  The first half of her career was in the Commercial Business to Business market, leading teams and selling products, software, and services. In 2001 she pivoted to Government Contracting, supporting the surge in National Security requirements for DoD and the Intelligence Community.  During her career Linda worked for an entrepreneurial startup company and formed two of her own. A COVID related furlough in May 2020 prompted her and two partners to form T2C.Linda grew up in California, moving several times with her Father’s Government career before landing at Mount Vernon High School in Alexandria, VA.  She graduated from Virginia Tech with a double major in Finance and Marketing Management and has an MBA from George Mason University. Linda lives in Herndon, VA with her husband Mike Ozycz. Their oldest son Zack graduated from JMU and is employed by Deltek GovWin IQ, middle son Bill graduated from Virginia Tech and is employed by Ernst and Young and their youngest son Eddie is a Freshman at Virginia Tech (GO HOKIES!!). 
Join us as Alex Hanlon, Ph.D. (Director of the Center for Biostatistics and Health Data Science at Virginia Tech,  Professor of Statistics and works closely with researchers on the Health Science and Technology Campus in Roanoke, adjacent to Carilion Clinic and the VTC School of Medicine) and Richard Bendis (Founder, President and CEO of BioHealth Innovation, Inc. and a successful entrepreneur, angel investor, innovation and technology-based economic development leader, international speaker and consultant in the technology and healthcare industries and host of BioTalk) discuss how ‘Big data requires team science.’ Additional show notes:Who funds the N3C initiative and what goes into it?The N3C is funded by the National Center for Advancing Translational Sciences (NCATS), which is part of the NIH or the National Institutes of Health. A key component of the initiative is data harmonization, which translates the differing ways that contributing hospitals store patient data into a single, common format to facilitate analyses. Participating sites add (or they will add) data on demographics, symptoms, medications, lab test results, and outcomes over a five-year period. This will enable both short- and long-term study of the impact of COVID-19 on health outcomes.Who has access to the N3C enclave data?Data access is open to all approved users, regardless of whether they contribute data. Details for gaining access can be found on the NCATS website (see link below). Researchers can request access only after their home institution has secured a data use agreement with NCATS. For those who are not associated with an institution, they will need to complete their own DUA with NCATS.https://ncats.nih.gov/n3c/about/applying-for-accessWhat kind of tools are available in the N3C enclave to support data analyses? The platform is built to support machine learning and rigorous statistical analyses using Python and R. The idea is to provide the necessary tools to address research questions using contemporary data driven techniques along with classical methods. To tackle such projects with large scale observational data requires collaboration within a team science environment, including expertise in statistics, informatics, medicine, engineering, and so on.
Communications and transparency; it’s how you lead. Amy talks about leadership philosophy from creating a company culture to hiring the right talent, and how to invest in your own growth. Check out the podcast and understand why it’s important to find your purpose and why you need a mentor.  About Qualtrax: Qualtrax works with companies to help them meet their assurance obligations and goals through document management, automating key business processes, streamlining training management and ensuring critical industry regulations are met.Qualtrax has around 340 clients, including Walmart, the D.C. Office of the Chief Medical Examiner, Colorado Bureau of Investigation, SABIC Innovative Plastics and the Arkansas State Crime Lab.
Join us for episode 5 as Brett talks with Bo Ewald, CEO of ColdQuanta, about quantum computing information systems, plus hear some great stories on Steve Jobs and more. Learn about ColdQuanta at https://www.coldquanta.com​. About ColdQuanta: ColdQuanta leads the market in commercializing quantum atomics, the next wave of the information age. Based on the company’s Quantum Core technology, ColdQuanta manufactures components, instruments, and turnkey systems that address a broad spectrum of applications. These range from timekeeping and navigation to quantum computing, and from radiofrequency (RF) receivers to quantum communications systems.
Virginia Tech alumnus George Probst is a photographer and public speaker. His website https://www.sharkpix.com​ showcases his love for the Great White Shark and the beauty of their distinct personalities. 
Join us for episode 3 as Brett takes you on a journey with Dan to learn how their products are powering exploration and discovery, the importance of mentoring, and challenges to being an entrepreneur. Learn more about VPT at http://www.vptpower.com​.
 Join Brett as he discusses drug discovery beneath the Antarctica ice, climate change, and the research James and Bill are conducting. McClintock bio: https://www.uab.edu/cas/biology/people/faculty/james-b-mcclintockRead opinion article by McClintock - 'Pandemic isolation tips: routine, hobbies, hope, dress in drag' https://www.al.com/opinion/2021/02/pandemic-isolation-tips-routine-hobbies-hope-dress-in-drag.htmlBaker bio: https://www.usf.edu/arts-sciences/departments/chemistry/faculty/baker.aspxLearn more about the Baker Research Group http://www.bakerchemistry.com​ Other link of interest: David Kingston at Virginia Tech: https://chem.vt.edu/people/faculty/dkingston.html
President & CEO, Brett Malone, Ph.D. talks with Erik Gatenholm, CEO of Cellink, with honors that include Innovator of the Year, Founder of the Year, and has been listed in Forbes Magazine's 30 Under 30 and MIT Review’s 35 Under 35.Listen as Erik talks about how Cellink is disrupting the biotech industry.
Comments 
Download from Google Play
Download from App Store